249 related articles for article (PubMed ID: 3621677)
1. Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3.
Rødgaard A; Nielsen FC; Djurup R; Somnier F; Gammeltoft S
Clin Exp Immunol; 1987 Jan; 67(1):82-8. PubMed ID: 3621677
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of serum IgG subclass concentrations in myasthenia gravis patients.
Liu Y; Wang W; Li J
Int J Neurosci; 2011 Oct; 121(10):570-4. PubMed ID: 21770714
[TBL] [Abstract][Full Text] [Related]
3. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
[TBL] [Abstract][Full Text] [Related]
4. A triple antibody assay for the quantitation of plasma IgG subclass antibodies to acetylcholine receptors in patients with myasthenia gravis.
Nielsen FC; Rødgaard A; Djurup R; Somnier F; Gammeltoft S
J Immunol Methods; 1985 Nov; 83(2):249-58. PubMed ID: 3902978
[TBL] [Abstract][Full Text] [Related]
5. Humoral immunity in myasthenia gravis: biochemical characterization of acquired antireceptor antibodies and clinical correlations.
Tindall RS
Ann Neurol; 1981 Nov; 10(5):437-47. PubMed ID: 7305297
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenic antibodies in myasthenia gravis].
Motomura M
Brain Nerve; 2010 Apr; 62(4):411-8. PubMed ID: 20420182
[TBL] [Abstract][Full Text] [Related]
7. [Antibodies in myasthenia gravis].
Eymard B
Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis.
Higuchi O; Hamuro J; Motomura M; Yamanashi Y
Ann Neurol; 2011 Feb; 69(2):418-22. PubMed ID: 21387385
[TBL] [Abstract][Full Text] [Related]
9. Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1.
Niks EH; van Leeuwen Y; Leite MI; Dekker FW; Wintzen AR; Wirtz PW; Vincent A; van Tol MJ; Jol-van der Zijde CM; Verschuuren JJ
J Neuroimmunol; 2008 Mar; 195(1-2):151-6. PubMed ID: 18384886
[TBL] [Abstract][Full Text] [Related]
10. Humoral immunity in myasthenia gravis: clinical correlations of anti-receptor antibody avidity and titer.
Tindall RS
Ann N Y Acad Sci; 1981; 377():316-31. PubMed ID: 6803647
[TBL] [Abstract][Full Text] [Related]
11. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
Vincent A; Newsom-Davis J
Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
[TBL] [Abstract][Full Text] [Related]
12. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
[TBL] [Abstract][Full Text] [Related]
13. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
14. [Value of acetylcholine receptor antibodies in myasthenia gravis].
Zeitlhofer J; Maida EM; Mamoli B; Mayr N
Wien Med Wochenschr; 1986 Jul; 136(13):329-32. PubMed ID: 3765651
[TBL] [Abstract][Full Text] [Related]
15. Acetylcholine receptor antibodies in myasthenia gravis.
Kornfeld P; Nall J; Smith H; Mittag TW; Bender AN; Ambinder EP; Horowitz SH; Papatestas AE; Gross H; Genkins G
Muscle Nerve; 1981; 4(5):413-9. PubMed ID: 6974823
[TBL] [Abstract][Full Text] [Related]
16. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes.
Ofosu-Appiah W; Mokhtarian F; Shirazian D; Grob D
J Lab Clin Med; 1994 Aug; 124(2):231-41. PubMed ID: 8051487
[TBL] [Abstract][Full Text] [Related]
17. Multiple forms of anti-acetylcholine receptor antibody in myasthenia gravis.
Mittag T; Massa T; Kornfeld P; Papatestas A; Bender A; Genkins G
Muscle Nerve; 1981; 4(1):16-25. PubMed ID: 6164920
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles.
Vincent A; Newsom-Davis J
Clin Exp Immunol; 1982 Aug; 49(2):257-65. PubMed ID: 6813004
[TBL] [Abstract][Full Text] [Related]
19. IgG from "seronegative" myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor.
Blaes F; Beeson D; Plested P; Lang B; Vincent A
Ann Neurol; 2000 Apr; 47(4):504-10. PubMed ID: 10762162
[TBL] [Abstract][Full Text] [Related]
20. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
